Cabaletta Bio, Inc.

CABA · XNAS

CIK 1759138fmd_0HQNR72BC1MTBVH1Y3G1RV0T4CManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 2018 to Sep 30, 2026, 34 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.